The aging male: androgens, erectile dysfunction, and depression.

Area of Science:

• Endocrinology
• Geriatrics
• Men's Health

Background:

• Men do not undergo menopause, but experience a progressive decline in hypothalamic-pituitary-gonadal (HPG) axis activity with age.
• This age-related HPG axis hypofunctioning is associated with symptoms like fatigue, reduced muscle/bone mass, sexual dysfunction, and depression in elderly men.
• The correlation between these symptoms and actual testosterone levels remains unclear.

Purpose of the Study:

• To review the relationship between androgens, sexual function, and depression in aging men.
• To discuss the implications of age-related hypogonadism and testosterone replacement therapy.

Main Methods:

• Literature review of studies on androgens, aging men, sexual function, and depression.
• Analysis of the effects of testosterone decline and replacement therapy.

Main Results:

• Testosterone levels and their circadian rhythm decrease progressively in aging men.
• Testosterone replacement therapy shows limited efficacy in reversing symptoms of mild, age-related hypogonadism.
• The direct link between testosterone levels and common symptoms in elderly men requires further investigation.

Conclusions:

• Age-related decline in HPG axis function affects aging men, but its sequelae are not consistently correlated with testosterone levels.
• Testosterone replacement therapy may not be effective for all aging men with mild hypogonadism.
• Further research is needed to understand the complex interplay of androgens, sexual function, and depression in older men.